Literature DB >> 2183858

What is meant by a "controlled" ventricular rate in atrial fibrillation?

J M Rawles1.   

Abstract

Reduction of a rapid ventricular rate in atrial fibrillation results in a longer diastolic filling period and a higher left ventricular stroke volume but this is offset by reduced contractility and fewer beats per minute; the net effect on cardiac output is uncertain. Sequences of stroke distances were measured by Doppler ultrasound in 60 resting patients with atrial fibrillation to determine the relation between ventricular rate and linear cardiac output. The slope of the cardiac output/ventricular rate relation was positive in all 20 patients with a ventricular rate less than 90 beats per minute and negative in 16 (40%) of 40 patients with a ventricular rate greater than 90 beats per minute. In atrial fibrillation the ventricular rate can be regarded as "controlled" when the cardiac output/ventricular rate slope is positive and "uncontrolled" when the slope is negative--that is when reduction of ventricular rate would lead to increased cardiac output. As so defined, ventricular rate at rest was controlled in every patient when the ventricular rate was less than 90, controlled in 44 (73%) patients when the ventricular rate was 90-140 beats per minute, and uncontrolled in every case when it was greater than 140 beats per minute. Achieving a target ventricular rate of 90 beats per minute in patients with atrial fibrillation at rest would result in control with the least compromise of cardiac output.

Entities:  

Mesh:

Year:  1990        PMID: 2183858      PMCID: PMC1024395          DOI: 10.1136/hrt.63.3.157

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  10 in total

1.  The haemodynamic basis of the symptoms and signs in mitral valvular disease.

Authors:  G WADE; L WERKO; H ELIASCH; A GIDLUND; H LAGERLOF
Journal:  Q J Med       Date:  1952-10

2.  A mathematical model of left ventricular function in atrial fibrillation.

Authors:  J M Rawles
Journal:  Int J Biomed Comput       Date:  1988-10

3.  Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.

Authors:  R Beasley; D A Smith; D J McHaffie
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

4.  Left atrial transport function in myocardial infarction. Importance of its booster pump function.

Authors:  S H Rahimtoola; A Ehsani; M Z Sinno; H S Loeb; K M Rosen; R M Gunnar
Journal:  Am J Med       Date:  1975-11       Impact factor: 4.965

5.  Towards improved control of atrial fibrillation.

Authors:  K S Channer; M Papouchado; M A James; D W Pitcher; J R Rees
Journal:  Eur Heart J       Date:  1987-02       Impact factor: 29.983

6.  How far is the cardiac output?

Authors:  N E Haites; F M McLennan; D H Mowat; J M Rawles
Journal:  Lancet       Date:  1984-11-03       Impact factor: 79.321

7.  Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem.

Authors:  R V Lewis; N Irvine; D G McDevitt
Journal:  Eur Heart J       Date:  1988-07       Impact factor: 29.983

8.  Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent.

Authors:  D David; E D Segni; H O Klein; E Kaplinsky
Journal:  Am J Cardiol       Date:  1979-12       Impact factor: 2.778

9.  Assessment of cardiac output by the Doppler ultrasound technique alone.

Authors:  N E Haites; F M McLennan; D H Mowat; J M Rawles
Journal:  Br Heart J       Date:  1985-02

10.  Mitral valve early diastolic closing velocity in the echocardiogram: relation to sequential diastolic flow and ventricular compliance.

Authors:  A N DeMaria; R R Miller; E A Amsterdam; W Markson; D T Mason
Journal:  Am J Cardiol       Date:  1976-04       Impact factor: 2.778

  10 in total
  32 in total

Review 1.  Physiology and pathophysiology of the atria: its role in atrial fibrillation.

Authors:  J Godtfredsen
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

2.  Determination of the target ventricular rate in patients with atrial fibrillation by evaluation of ventriculoarterial coupling.

Authors:  Sachihiko Nobuoka; Seiji Hatano; Junzo Nagashima; Akihiro Yoshida; Hisanobu Adachi; Yukiko Imai; Masaaki Shibamoto; Kyoko Ikeda; Fumihiko Miyake
Journal:  Tex Heart Inst J       Date:  2002

Review 3.  Rate control in the medical management of atrial fibrillation.

Authors:  A J Camm; I Savelieva; G Y H Lip
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

4.  Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects.

Authors:  V H Deneer; L Lie-A-Huen; J H Kingma; J H Proost; J C Kelder; J R Brouwers
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

5.  Management of Atrial Fibrillation: Identifying and treating the causes.

Authors:  S W Rabkin
Journal:  Can Fam Physician       Date:  1991-03       Impact factor: 3.275

6.  Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.

Authors:  Bart A Mulder; Kevin Damman; Dirk J Van Veldhuisen; Isabelle C Van Gelder; Michiel Rienstra
Journal:  Clin Cardiol       Date:  2017-05-17       Impact factor: 2.882

Review 7.  Atrial fibrillation: how to approach rate control.

Authors:  Lynda E Rosenfeld
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

Review 8.  Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.

Authors:  Giuseppe Boriani; Mauro Biffi; Igor Diemberger; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Emergency management of atrial fibrillation.

Authors:  A Wakai; J O O'Neill
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401

Review 10.  Evolving concepts in the treatment of atrial fibrillation.

Authors:  Parimal B Maniar; Jonathan S Steinberg
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.